Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled "Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats," held on May 20, 2019.

Original publication

DOI

10.1111/nyas.14235

Type

Journal article

Journal

Annals of the New York Academy of Sciences

Publication Date

02/2020

Volume

1462

Pages

14 - 26

Addresses

Science Writer, New York, New York.

Keywords

Animals, Humans, Communicable Diseases, Communicable Diseases, Emerging, Vaccines, Therapies, Investigational, Communicable Disease Control, New York City, Clinical Trials as Topic, Congresses as Topic, Research Report